| scholarly article | Q13442814 |
| P50 | author | Mélanie Kremer | Q90625252 |
| P2093 | author name string | Michel Barrot | |
| Ipek Yalcin | |||
| Eric Salvat | |||
| Laurent Nexon | |||
| Rhian Alice Ceredig | |||
| Xavier Wurtz | |||
| Dominique Massotte | |||
| Salim Megat | |||
| Yohann Bohren | |||
| Stéphane Doridot | |||
| P2860 | cites work | A Dual Noradrenergic Mechanism for the Relief of Neuropathic Allodynia by the Antidepressant Drugs Duloxetine and Amitriptyline. | Q64934471 |
| Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human | Q72413362 | ||
| Peripheral Delta Opioid Receptors Mediate Formoterol Anti-allodynic Effect in a Mouse Model of Neuropathic Pain | Q89963750 | ||
| Peripheral delta opioid receptors mediate duloxetine antiallodynic effect in a mouse model of neuropathic pain | Q90609786 | ||
| Recommendations for the pharmacological management of neuropathic pain: an overview and literature update | Q24616897 | ||
| A comparison of the antinociceptive and adverse effects of the mu-opioid agonist morphine and the delta-opioid agonist SNC80 | Q28255208 | ||
| Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation | Q28345401 | ||
| Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine | Q28371472 | ||
| Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal | Q28379331 | ||
| Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses | Q28510086 | ||
| Targeted disruption of the beta2 adrenergic receptor gene | Q28510519 | ||
| Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment | Q33569509 | ||
| Pain genes?: natural variation and transgenic mutants | Q33938663 | ||
| Antidepressants and pain | Q33996645 | ||
| EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision | Q34110857 | ||
| Epigenetic mechanisms of depression and antidepressant action | Q34302493 | ||
| β2-agonist therapy in lung disease | Q34324300 | ||
| The sciatic nerve cuffing model of neuropathic pain in mice | Q34442972 | ||
| Pathophysiology of depression: the concept of synaptic plasticity | Q34548351 | ||
| Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia | Q34662147 | ||
| Opioid receptor genes inactivated in mice: the highlights. | Q34930345 | ||
| Antidepressants suppress neuropathic pain by a peripheral β2-adrenoceptor mediated anti-TNFα mechanism | Q34974517 | ||
| Dissociation of the opioid receptor mechanisms that control mechanical and heat pain | Q34986633 | ||
| Opioid receptors and opioid peptide-producing leukocytes in inflammatory pain--basic and therapeutic aspects | Q35010637 | ||
| κ-Opioid receptors are not necessary for the antidepressant treatment of neuropathic pain | Q35039212 | ||
| Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia | Q35748006 | ||
| The antiallodynic action of pregabalin in neuropathic pain is independent from the opioid system | Q35974778 | ||
| Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches | Q36438816 | ||
| Antidepressants for neuropathic pain: a Cochrane review. | Q37764627 | ||
| Tests and models of nociception and pain in rodents | Q37975822 | ||
| Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between | Q38289893 | ||
| The antiallodynic action of nortriptyline and terbutaline is mediated by β(2) adrenoceptors and δ opioid receptors in the ob/ob model of diabetic polyneuropathy | Q38310236 | ||
| Delta opioid agonists: a concise update on potential therapeutic applications | Q38366279 | ||
| Antidepressant drug action--From rapid changes on network function to network rewiring. | Q38525290 | ||
| Antidepressants and gabapentinoids in neuropathic pain: Mechanistic insights. | Q38892780 | ||
| Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy | Q39501933 | ||
| A Brainstem-Spinal Cord Inhibitory Circuit for Mechanical Pain Modulation by GABA and Enkephalins | Q40349158 | ||
| The composition of the beta-2 adrenergic receptor oligomer affects its membrane trafficking after ligand-induced endocytosis | Q40502781 | ||
| Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene | Q41157124 | ||
| Effects of β2 agonists on post-thoracotomy pain incidence. | Q41232343 | ||
| Is there a place for beta-mimetics in clinical management of neuropathic pain? Salbutamol therapy in six cases. | Q43097713 | ||
| Chronic treatment with agonists of beta(2)-adrenergic receptors in neuropathic pain. | Q43258730 | ||
| The role of delta-opioid receptor subtypes in neuropathic pain | Q43540650 | ||
| Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved | Q44330782 | ||
| Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain | Q44331988 | ||
| The antinociceptive effects of a δ-opioid receptor agonist in mice with painful diabetic neuropathy: Involvement of heme oxygenase 1. | Q44334700 | ||
| Delta Opioid Receptor (DOR) Ligands and Pharmacology: Development of Indolo- and Quinolinomorphinan Derivatives Based on the Message-Address Concept | Q44341032 | ||
| Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats | Q44341809 | ||
| Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia | Q44342783 | ||
| Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue | Q44346015 | ||
| The role of nitric oxide in the local antiallodynic and antihyperalgesic effects and expression of delta-opioid and cannabinoid-2 receptors during neuropathic pain in mice. | Q44346644 | ||
| Neuropathic pain is enhanced in delta-opioid receptor knockout mice | Q44351896 | ||
| beta(2)-adrenoceptors are critical for antidepressant treatment of neuropathic pain | Q46101200 | ||
| Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain | Q46197540 | ||
| Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice | Q46709181 | ||
| Modulation of P2X receptors via adrenergic pathways in rat dorsal root ganglion neurons after sciatic nerve injury | Q46855698 | ||
| Sciatic nerve cuffing in mice: a model of sustained neuropathic pain | Q46897992 | ||
| Combination of immunocytochemistry and radioligand receptor assay to identify beta-adrenergic receptor subtypes on astroglia in vitro | Q48665215 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 1744806920912931 | |
| P577 | publication date | 2020-01-01 | |
| P1433 | published in | Molecular Pain | Q15766244 |
| P1476 | title | Delta opioid receptors are essential to the antiallodynic action of Β2-mimetics in a model of neuropathic pain | |
| P478 | volume | 16 |
Search more.